Select Water Solutions heads into its Q1 2026 earnings today with options positioning markedly more defensive than usual, even as short sellers quietly retreat.
The clearest signal is in the options market. The put/call ratio jumped to 0.116 — more than two standard deviations above its 20-day mean of 0.053, a z-score of 2.01. That makes it the most defensive options posture on the stock in recent memory relative to its own baseline, even though the ratio remains low in absolute terms. The shift is notable because it arrived abruptly: the PCR doubled over a matter of days as the stock rallied, suggesting some investors are hedging a move they don't fully trust. The stock itself has had a strong run — up 13.6% over the past month and 4.4% on the week to close at $17.25 on Tuesday.
Short interest tells a different story. Bears have pulled back meaningfully from the April highs. SI as a percentage of the free float is now 4.8%, down from a peak near 5.9% in mid-April. The week-over-week increase of 16% in shares short is worth watching, but that largely reflects a recovery from a single-day spike on April 30 that quickly reversed. Borrow conditions remain almost entirely unconstrained: the cost to borrow is just 0.39% and has eased more than 20% over the week. Availability is wide, meaning the lending pool is far from stressed. There is no short-squeeze pressure embedded in this setup.
The analyst community is constructive but mildly behind the stock's recent re-rating. The consensus mean target is $18.00, barely above the current price of $17.25. Citigroup lifted its target to $18 in early April — notably after the stock had already begun rallying — while maintaining its Buy rating. Piper Sandler raised its target to $16 in late February, still below where the stock now trades. The forward EPS growth outlook ranks in the 79th percentile against the broader universe, a genuine bright spot, though the EPS surprise track record sits in only the 14th percentile — meaning beats have been rare historically. On valuation, the P/E sits near 39.8x, not cheap for an oilfield services name, though the EV/EBITDA of 7.3x remains more modest. The two most recent earnings prints produced a 7.2% and 2.9% one-day gain respectively, which will inform how aggressively both sides position into today's release.
The institutional register is active. Franklin Resources added 2.79 million shares as of March 31, a material increase. Crestview Partners — a private equity 10% owner with board representation — sold roughly 3.1 million shares on April 8 at $15.12, reducing its position by a meaningful amount. CEO John Schmitz also trimmed a modest $693k worth of stock in early March, though he remains a significant holder. The combined net insider activity over the past 90 days reflects a large positive share count, distorted by equity awards rather than open-market buying.
The print will test whether the Q1 revenue run rate — estimated near $345 million — and EBITDA delivery justify a stock that has re-rated sharply higher, with analysts' targets now sitting almost exactly at the current price.
See the live data behind this article on ORTEX.
Open WTTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
